首页 > 市场调查报告书 > 医疗设备

e保健

市场调查报告书

商品编码

1922801

日本网路药局市场规模、份额、趋势及预测（依药品类型、产品类型、平台、支付方式及地区划分，2026-2034年）

Japan E-Pharmacy Market Size, Share, Trends and Forecast by Drug Type, Product Type, Platform, Payment Method, and Region, 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 122 Pages | 商品交期: 5-7个工作天内

价格

简介目录

日本网路药局市场规模在2025年达到71亿美元。 IMARC集团预测，到2034年，该市场规模将达到205亿美元，2026年至2034年的复合年增长率（CAGR）为12.43%。推动市场显着增长的因素包括人口老化、慢性疾病患者数量增加、数位技术的广泛应用以及监管支持。此外，对远距处方笺和便利性的需求不断增长，也推动了对基于应用程式的平台、处方笺服务和线上医疗整合的投资。

日本线上药局市场的发展趋势：

放宽对网路药品销售的监管

日本的法规环境正逐步向数位化医疗转型，为线上药局产业的成长创造了空间。例如，继Google宣布政策调整后，日本于2024年12月宣布计画允许获得许可的线上药局和远端医疗服务提供者从2025年1月起开始宣传处方药服务。服务提供者必须获得厚生劳动省的许可或LegitScript认证，并接受Google的额外检验。逐步放宽对非处方药和部分处方药线上销售的监管，是推动日本网路药局市场成长的主要动力。监管调整后，药局现在可以提供线上咨询、远端处方笺处理和直接送货上门服务。这些变化鼓励了现有连锁药局和新参与企业投资于数位基础设施和服务整合。透过允许药品分发和取得方式柔软性，法规结构与数位化医疗和消费者便利性的整体趋势相契合。预计这一环境将进一步发展，促进市场参与企业之间的竞争和创新。这项转变也反映了政府在不影响安全性和合规性的前提下，实现药品取得途径现代化的意图。随着这些变革的逐步落实，很可能会对日本的线上药局市占率产生直接影响。

高龄化社会与慢性病管理

日本人口老化正显着影响着医疗服务的提供方式。这种人口结构的变化推动了对便利居家医疗解决方案的需求，尤其对于需要管理高血压、糖尿病和心血管疾病等慢性病的人。据报道，目前日本超过十分之一的人口年龄在80岁及以上，约有三分之一的人口（约3,623万人）年龄在65岁及以上。日本仍然是世界上老化程度最高的国家之一。网路药局平台透过提供简化的处方笺续药服务、用药提醒和客製化的宅配服务来满足这项需求。许多服务都优化了用户体验，例如语音引导应用程式、放大的介面文字以及与看护者整合的帐户。这些平台不仅减少了老年人去药局的次数，还有助于维持治疗的连续性，这对慢性病管理至关重要。随着老年人数位素养的提高和支持系统的完善，预计网路药局的普及率将进一步扩大。这种人口结构的变化是影响日本网路药局市场前景的关键因素。

本报告解答的关键问题

日本网路药局市场目前发展状况如何？未来几年又将如何发展？
日本网路药局市场按药品类型分類的市场组成是什么？
日本网路药局市场依产品类型分類的组成是怎样的？
日本线上药局市场按平台分類的市占率构成是什么？
日本线上药局市场按支付方式是如何细分的？
日本线上药局市场按地区分類的市场组成是什么？
请介绍一下日本线上药局市场价值链的各个环节。
日本线上药局市场的主要驱动因素和挑战是什么？
日本线上药局市场的结构是怎样的？主要参与者有哪些？
日本网路药局市场竞争有多激烈？

The Japan e-pharmacy market size reached USD 7.10 Billion in 2025 . Looking forward, IMARC Group expects the market to reach USD 20.50 Billion by 2034 , exhibiting a growth rate (CAGR) of 12.43% during 2026-2034 . The market is experiencing significant growth, driven by an aging population, growing chronic illness cases, digital adoption, and regulatory support. Moreover, increased demand for remote prescriptions and convenience is encouraging investments in app-based platforms, prescription services, and online healthcare integration.

JAPAN E-PHARMACY MARKET TRENDS:

Regulatory Relaxation for Online Drug Sales

Japan's regulatory environment has steadily become more supportive of digital healthcare, creating room for growth in the online pharmacy sector. For instance, in December 2024, Japan announced its plans to permit licensed online pharmacies and telemedicine providers to advertise prescription drug services starting January 2025, following a policy shift announced by Google. Providers must secure MHLW licensing or LegitScript certification and undergo additional Google verification. The gradual relaxation of rules around the online sale of over-the-counter and certain prescription drugs has been a key driver behind Japan e-pharmacy market growth. Regulatory adjustments have enabled pharmacies to offer digital consultations, process prescriptions remotely, and deliver medications directly to consumers. These shifts have encouraged both established pharmacy chains and new entrants to invest in digital infrastructure and service integration. By allowing more flexibility in how medications are dispensed and accessed, the regulatory framework is aligning with broader trends in digital health and consumer convenience. This environment is expected to further evolve, enabling stronger competition and innovation among market participants. This transformation also reflects the government's intent to modernize pharmaceutical access without compromising safety or compliance. As these changes take root, they are likely to have a direct impact on Japan e-pharmacy market share.

To get more information on this market Request Sample

Rising Aging Population and Chronic Disease Management

Japan's aging population is significantly influencing how healthcare services are delivered. This demographic shift has increased demand for accessible, home-based medication solutions, particularly for those managing chronic conditions like hypertension, diabetes, and cardiovascular diseases. According to reports, more than 1 in 10 people in Japan are now aged 80 or older, with nearly a third of the population (approximately 36.23 million) over 65. Japan's demographic remains the oldest globally. E-pharmacy platforms are stepping in to address this need by offering simplified prescription refill services, medication reminders, and home delivery tailored to elderly users. Many services are now optimized for ease of use, including voice-guided apps, larger interface text, and caregiver-linked accounts. These platforms not only reduce the need for physical visits to pharmacies but also support ongoing treatment adherence-critical in chronic disease management. As digital literacy improves among older adults and support systems around them strengthen, e-pharmacy adoption is expected to rise further. This demographic-driven shift is a central factor shaping the Japan e-pharmacy market outlook.

JAPAN E-PHARMACY MARKET SEGMENTATION:

Drug Type Insights:

Over the Counter (OTC) Drugs
Prescription Drugs
Over the Counter (OTC) Drugs
Prescription Drugs

Product Type Insights:

Access the comprehensive market breakdown Request Sample
Skin Care
Dental
Cold and Flu
Vitamins
Weight Loss
Others
Skin Care
Dental
Cold and Flu
Vitamins
Weight Loss
Others

Platform Insights:

App-Based
Web-Based
App-Based
Web-Based

Payment Method Insights:

Cash on Delivery
Online Payment
Cash on Delivery
Online Payment

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
Kanto Region
Kansai/Kinki Region
Central/Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central /Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

KEY QUESTIONS ANSWERED IN THIS REPORT
How has the Japan e-pharmacy market performed so far and how will it perform in the coming years?
What is the breakup of the Japan e-pharmacy market on the basis of drug type?
What is the breakup of the Japan e-pharmacy market on the basis of product type?
What is the breakup of the Japan e-pharmacy market on the basis of platform?
What is the breakup of the Japan e-pharmacy market on the basis of payment method?
What is the breakup of the Japan e-pharmacy market on the basis of region?
What are the various stages in the value chain of the Japan e-pharmacy market?
What are the key driving factors and challenges in the Japan e-pharmacy?
What is the structure of the Japan e-pharmacy market and who are the key players?
What is the degree of competition in the Japan e-pharmacy market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan E-Pharmacy Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan E-Pharmacy Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan E-Pharmacy Market - Breakup by Drug Type

6.1 Over the Counter (OTC) Drugs
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Prescription Drugs
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)

7 Japan E-Pharmacy Market - Breakup by Product Type

7.1 Skin Care
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Dental
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
7.3 Cold and Flu
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2020-2025)
- 7.3.3 Market Forecast (2026-2034)
7.4 Vitamins
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2020-2025)
- 7.4.3 Market Forecast (2026-2034)
7.5 Weight Loss
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2020-2025)
- 7.5.3 Market Forecast (2026-2034)
7.6 Others
- 7.6.1 Historical and Current Market Trends (2020-2025)
- 7.6.2 Market Forecast (2026-2034)

8 Japan E-Pharmacy Market - Breakup by Platform

8.1 App-Based
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Web-Based
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)

9 Japan E-Pharmacy Market - Breakup by Payment Method

9.1 Cash on Delivery
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Forecast (2026-2034)
9.2 Online Payment
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Forecast (2026-2034)

10 Japan E-Pharmacy Market - Breakup by Region

10.1 Kanto Region
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2020-2025)
- 10.1.3 Market Breakup by Drug Type
- 10.1.4 Market Breakup by Product Type
- 10.1.5 Market Breakup by Platform
- 10.1.6 Market Breakup by Payment Method
- 10.1.7 Key Players
- 10.1.8 Market Forecast (2026-2034)
10.2 Kansai/Kinki Region
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2020-2025)
- 10.2.3 Market Breakup by Drug Type
- 10.2.4 Market Breakup by Product Type
- 10.2.5 Market Breakup by Platform
- 10.2.6 Market Breakup by Payment Method
- 10.2.7 Key Players
- 10.2.8 Market Forecast (2026-2034)
10.3 Central/ Chubu Region
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2020-2025)
- 10.3.3 Market Breakup by Drug Type
- 10.3.4 Market Breakup by Product Type
- 10.3.5 Market Breakup by Platform
- 10.3.6 Market Breakup by Payment Method
- 10.3.7 Key Players
- 10.3.8 Market Forecast (2026-2034)
10.4 Kyushu-Okinawa Region
- 10.4.1 Overview
- 10.4.2 Historical and Current Market Trends (2020-2025)
- 10.4.3 Market Breakup by Drug Type
- 10.4.4 Market Breakup by Product Type
- 10.4.5 Market Breakup by Platform
- 10.4.6 Market Breakup by Payment Method
- 10.4.7 Key Players
- 10.4.8 Market Forecast (2026-2034)
10.5 Tohoku Region
- 10.5.1 Overview
- 10.5.2 Historical and Current Market Trends (2020-2025)
- 10.5.3 Market Breakup by Drug Type
- 10.5.4 Market Breakup by Product Type
- 10.5.5 Market Breakup by Platform
- 10.5.6 Market Breakup by Payment Method
- 10.5.7 Key Players
- 10.5.8 Market Forecast (2026-2034)
10.6 Chugoku Region
- 10.6.1 Overview
- 10.6.2 Historical and Current Market Trends (2020-2025)
- 10.6.3 Market Breakup by Drug Type
- 10.6.4 Market Breakup by Product Type
- 10.6.5 Market Breakup by Platform
- 10.6.6 Market Breakup by Payment Method
- 10.6.7 Key Players
- 10.6.8 Market Forecast (2026-2034)
10.7 Hokkaido Region
- 10.7.1 Overview
- 10.7.2 Historical and Current Market Trends (2020-2025)
- 10.7.3 Market Breakup by Drug Type
- 10.7.4 Market Breakup by Product Type
- 10.7.5 Market Breakup by Platform
- 10.7.6 Market Breakup by Payment Method
- 10.7.7 Key Players
- 10.7.8 Market Forecast (2026-2034)
10.8 Shikoku Region
- 10.8.1 Overview
- 10.8.2 Historical and Current Market Trends (2020-2025)
- 10.8.3 Market Breakup by Drug Type
- 10.8.4 Market Breakup by Product Type
- 10.8.5 Market Breakup by Platform
- 10.8.6 Market Breakup by Payment Method
- 10.8.7 Key Players
- 10.8.8 Market Forecast (2026-2034)

11 Japan E-Pharmacy Market - Competitive Landscape

11.1 Overview
11.2 Market Structure
11.3 Market Player Positioning
11.4 Top Winning Strategies
11.5 Competitive Dashboard
11.6 Company Evaluation Quadrant

12 Profiles of Key Players

12.1 Company A
- 12.1.1 Business Overview
- 12.1.2 Services Offered
- 12.1.3 Business Strategies
- 12.1.4 SWOT Analysis
- 12.1.5 Major News and Events
12.2 Company B
- 12.2.1 Business Overview
- 12.2.2 Services Offered
- 12.2.3 Business Strategies
- 12.2.4 SWOT Analysis
- 12.2.5 Major News and Events
12.3 Company C
- 12.3.1 Business Overview
- 12.3.2 Services Offered
- 12.3.3 Business Strategies
- 12.3.4 SWOT Analysis
- 12.3.5 Major News and Events
12.4 Company D
- 12.4.1 Business Overview
- 12.4.2 Services Offered
- 12.4.3 Business Strategies
- 12.4.4 SWOT Analysis
- 12.4.5 Major News and Events
12.5 Company E
- 12.5.1 Business Overview
- 12.5.2 Services Offered
- 12.5.3 Business Strategies
- 12.5.4 SWOT Analysis
- 12.5.5 Major News and Events

13 Japan E-Pharmacy Market - Industry Analysis

13.1 Drivers, Restraints, and Opportunities
- 13.1.1 Overview
- 13.1.2 Drivers
- 13.1.3 Restraints
- 13.1.4 Opportunities
13.2 Porters Five Forces Analysis
- 13.2.1 Overview
- 13.2.2 Bargaining Power of Buyers
- 13.2.3 Bargaining Power of Suppliers
- 13.2.4 Degree of Competition
- 13.2.5 Threat of New Entrants
- 13.2.6 Threat of Substitutes
13.3 Value Chain Analysis